Litigation Details for SHIRE PHARMACEUTICAL DEVELOPMENT INC. v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2015)
✉ Email this page to a colleague
SHIRE PHARMACEUTICAL DEVELOPMENT INC. v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2015)
| Docket | 1:15-cv-02865 | Date Filed | 2015-04-22 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-05-21 |
| Cause | 35:271 Patent Infringement | Assigned To | Robert B. Kugler |
| Jury Demand | None | Referred To | Joel Schneider |
| Patents | 6,773,720 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SHIRE PHARMACEUTICAL DEVELOPMENT INC. v. AMNEAL PHARMACEUTICALS LLC
The small molecule drug covered by the patent cited in this case is ⤷ Start Trial .
Details for SHIRE PHARMACEUTICAL DEVELOPMENT INC. v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-04-22 | External link to document | |||
| 2015-04-22 | 117 | certain terms contained with U.S. Patent 6,773,720 (the “ ’720 Patent”) pursuant to Markman v. Westview…intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history…construction for a given patent are binding on later district courts analyzing the same patent. See Key Pharms…district courts of the same terms in the same patent or patent family are highly relevant and persuasive…to “simple dispersion” elsewhere in the patent, (’720 Patent, col. 1 l. 53), signifying that dispersion | External link to document | |
| 2015-04-22 | 369 | Order | product that infringes U.S. Patent No. 6,773,720 ("the '720 patent"); WHEREAS, …;720 patent; WHEREAS, Defendants sought a declaratory judgment that the '720 patent is invalid…withdrew their claims of invalidity of the '720 patent. NOW, THEREFORE, Plaintiffs hereby request…its amendments, does not infringe the '720 patent; 2) Defendants' claims of invalidity… 2015 21 May 2018 1:15-cv-02865 830 Patent None District Court, D. New Jersey | External link to document |
| 2015-04-22 | 394 | covered by U.S. Patent Number 6,773,720 (“ ‘720 patent”).2 Claim 1 of the ‘720 patent recites a controlled‐release… On 22 April 2015, plaintiff Shire filed a patent infringement suit against defendants Amneal (“the…party. 2 According to the Orange Book, the ‘720 patent expires 8 Jun 2020. …applications before the FDA, Shire filed similar patent infringement cases against these ANDA applicants…this nor any other ANDA case involving the ’720 patent can be categorized as an unqualified prevail. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
